Skip to main content
Top
Published in:

Open Access 11-04-2024 | Chronic Obstructive Lung Disease | EM - ORIGINAL

Management of acute exacerbations of COPD in the emergency department and its associations with clinical variables

Authors: Ophir Freund, Ariel Melloul, Sabrina Fried, Eyal Kleinhendler, Avraham Unterman, Evgeni Gershman, Avishay Elis, Amir Bar-Shai

Published in: Internal and Emergency Medicine | Issue 8/2024

Login to get access

Abstract

Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a common cause for emergency department (ED) visits. Still, large scale studies that assess the management of AECOPD in the ED are limited. Our aim was to evaluate treatment characteristics of AE-COPD in the ED on a national scale. A prospective study as part of the COPD Israeli survey, conducted between 2017 and 2019, in 13 medical centers. Patients hospitalized with AECOPD were included and interviewed. Clinical data related to their ED and hospital stay were collected. 344 patients were included, 38% females, mean age of 70 ± 11 years. Median (IQR) time to first ED treatment was 59 (23–125) minutes and to admission 293 (173–490) minutes. Delayed ED treatment (> 1 h) was associated with older age (p = 0.01) and lack of a coded diagnosis of COPD in hospital records (p = 0.01). Long ED length-of-stay (> 5 h) was linked with longer hospitalizations (p = 0.01). Routine ED care included inhalations of short-acting bronchodilators (246 patients, 72%) and systemic steroids (188 patients, 55%). Receiving routine ED care was associated with its continuation during hospitalization (p < 0.001). In multivariate analysis, predictors for patients not receiving routine care were obesity (adjusted odds ratio 0.5, 95% CI 0.3–0.8, p = 0.01) and fever (AOR 0.3, 95% CI 0.1–0.6, p < 0.01), while oxygen saturation < 91% was an independent predictor for ED routine treatment (AOR 3.6, 95% CI 2.1–6.3, p < 0.01). Our findings highlight gaps in the treatment of AECOPD in the ED on a national scale, with specific predictors for their occurrence.
Literature
2.
go back to reference Safiri S, Carson-Chahhoud K, Noori M, Nejadghaderi SA, Sullman MJM, Heris JA, Ansarin K, Mansournia MA, Collins GS, Kolahi A-A, Kaufman JS (2022) Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990–2019: results from the global burden of disease study 2019. BMJ 378:e069679. https://doi.org/10.1136/bmj-2021-069679CrossRefPubMedPubMedCentral Safiri S, Carson-Chahhoud K, Noori M, Nejadghaderi SA, Sullman MJM, Heris JA, Ansarin K, Mansournia MA, Collins GS, Kolahi A-A, Kaufman JS (2022) Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990–2019: results from the global burden of disease study 2019. BMJ 378:e069679. https://​doi.​org/​10.​1136/​bmj-2021-069679CrossRefPubMedPubMedCentral
13.
go back to reference Germini F, Veronese G, Marcucci M, Coen D, Ardemagni D, Montano N, Fabbri A, Adinolfi LE, Alvisi A, Azin G, Balloni A, Bandiera G, Barchetti M, Barillari A, Barozzi M, Belloni G, Belotti E, Binetti N, Bonora M, Bruni R, Cacco S, Camisa D, Carbone G, Carpinteri G, Catino L, Cazzaniga M, Cenni P, Chelli V, Cicero L, Cottone CD, Cuccia F, D’Angelo L, Dalmonte F, Daviddi F, Vita AD, Famà F, Fedele M, Fonti C, Frigerio M, Gallingani A, Ghiglione V, Gioffrè-Florio M, Giordano M, Giostra F, Galli MG, Greggi ME, Groff P, Guizzardi S, Lagasio C, Lazzara G, Lubini E, Magni L, Mancarella S, Mangano G, Maragno M, Menabue M, Meoni E, Molinaro F, Morelli A, Moscariello F, Nevola R, Noto P, Pagano A, Paladino F, Pancani R, Petrelli G, Petrino R, Sinno C, Tafa A, Tartaglia S, Taurino C, Treleani M, Villari L, Vitelli A, Zaccagni C, Zaccaro B, Zacchino M (2018) COPD exacerbations in the emergency department: epidemiology and related costs a retrospective cohort multicentre study from the italian society of emergency medicine (SIMEU). Eur J Intern Med 51:74–79. https://doi.org/10.1016/j.ejim.2018.01.010CrossRefPubMed Germini F, Veronese G, Marcucci M, Coen D, Ardemagni D, Montano N, Fabbri A, Adinolfi LE, Alvisi A, Azin G, Balloni A, Bandiera G, Barchetti M, Barillari A, Barozzi M, Belloni G, Belotti E, Binetti N, Bonora M, Bruni R, Cacco S, Camisa D, Carbone G, Carpinteri G, Catino L, Cazzaniga M, Cenni P, Chelli V, Cicero L, Cottone CD, Cuccia F, D’Angelo L, Dalmonte F, Daviddi F, Vita AD, Famà F, Fedele M, Fonti C, Frigerio M, Gallingani A, Ghiglione V, Gioffrè-Florio M, Giordano M, Giostra F, Galli MG, Greggi ME, Groff P, Guizzardi S, Lagasio C, Lazzara G, Lubini E, Magni L, Mancarella S, Mangano G, Maragno M, Menabue M, Meoni E, Molinaro F, Morelli A, Moscariello F, Nevola R, Noto P, Pagano A, Paladino F, Pancani R, Petrelli G, Petrino R, Sinno C, Tafa A, Tartaglia S, Taurino C, Treleani M, Villari L, Vitelli A, Zaccagni C, Zaccaro B, Zacchino M (2018) COPD exacerbations in the emergency department: epidemiology and related costs a retrospective cohort multicentre study from the italian society of emergency medicine (SIMEU). Eur J Intern Med 51:74–79. https://​doi.​org/​10.​1016/​j.​ejim.​2018.​01.​010CrossRefPubMed
14.
go back to reference Kelly A-M, Van Meer O, Keijzers G, Motiejunaite J, Jones P, Body R, Craig S, Karamercan M, Klim S, Harjola V-P, Verschuren F, Holdgate A, Christ M, Golea A, Graham CA, Capsec J, Barletta C, Garcia-Castrillo L, Kuan WS, Laribi S, on behalf of the AANZDEM and EuroDEM Study Groups (2020) Get with the guidelines: management of chronic obstructive pulmonary disease in emergency departments in Europe and Australasia is sub-optimal. Intern Med J 50(2):200–208. https://doi.org/10.1111/imj.14323CrossRefPubMed Kelly A-M, Van Meer O, Keijzers G, Motiejunaite J, Jones P, Body R, Craig S, Karamercan M, Klim S, Harjola V-P, Verschuren F, Holdgate A, Christ M, Golea A, Graham CA, Capsec J, Barletta C, Garcia-Castrillo L, Kuan WS, Laribi S, on behalf of the AANZDEM and EuroDEM Study Groups (2020) Get with the guidelines: management of chronic obstructive pulmonary disease in emergency departments in Europe and Australasia is sub-optimal. Intern Med J 50(2):200–208. https://​doi.​org/​10.​1111/​imj.​14323CrossRefPubMed
17.
go back to reference Sivapalan P, Lapperre TS, Janner J, Laub RR, Moberg M, Bech CS, Eklöf J, Holm FS, Armbruster K, Sivapalan P, Mosbech C, Ali AKM, Seersholm N, Wilcke JT, Brøndum E, Sonne TP, Rønholt F, Andreassen HF, Ulrik CS, Vestbo J, Jensen J-US (2019) Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD Exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label. Non-Inferiority Trial Lancet Respir Med 7(8):699–709. https://doi.org/10.1016/S2213-2600(19)30176-6CrossRefPubMed Sivapalan P, Lapperre TS, Janner J, Laub RR, Moberg M, Bech CS, Eklöf J, Holm FS, Armbruster K, Sivapalan P, Mosbech C, Ali AKM, Seersholm N, Wilcke JT, Brøndum E, Sonne TP, Rønholt F, Andreassen HF, Ulrik CS, Vestbo J, Jensen J-US (2019) Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD Exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label. Non-Inferiority Trial Lancet Respir Med 7(8):699–709. https://​doi.​org/​10.​1016/​S2213-2600(19)30176-6CrossRefPubMed
18.
go back to reference Croskerry P (2003) The importance of cognitive errors in diagnosis and strategies to minimize them. Acad Med 78(8):775CrossRefPubMed Croskerry P (2003) The importance of cognitive errors in diagnosis and strategies to minimize them. Acad Med 78(8):775CrossRefPubMed
28.
go back to reference Nakao S, Vaillancourt C, Taljaard M, Nemnom M-J, Woo MY, Stiell IG (2020) Evaluating the impact of point-of-care ultrasonography on patients with suspected acute heart failure or chronic obstructive pulmonary disease exacerbation in the emergency department: a prospective observational study. Can J Emerg Med 22(3):342–349. https://doi.org/10.1017/cem.2019.499CrossRef Nakao S, Vaillancourt C, Taljaard M, Nemnom M-J, Woo MY, Stiell IG (2020) Evaluating the impact of point-of-care ultrasonography on patients with suspected acute heart failure or chronic obstructive pulmonary disease exacerbation in the emergency department: a prospective observational study. Can J Emerg Med 22(3):342–349. https://​doi.​org/​10.​1017/​cem.​2019.​499CrossRef
29.
go back to reference Casalino E, Wargon M, Peroziello A, Choquet C, Leroy C, Beaune S, Pereira L, Bernard J, Buzzi J-C (2014) Predictive factors for longer length of stay in an emergency department: a prospective multicentre study evaluating the impact of age, patient’s clinical acuity and complexity, and care pathways. Emerg Med J 31(5):361–368. https://doi.org/10.1136/emermed-2012-202155CrossRefPubMed Casalino E, Wargon M, Peroziello A, Choquet C, Leroy C, Beaune S, Pereira L, Bernard J, Buzzi J-C (2014) Predictive factors for longer length of stay in an emergency department: a prospective multicentre study evaluating the impact of age, patient’s clinical acuity and complexity, and care pathways. Emerg Med J 31(5):361–368. https://​doi.​org/​10.​1136/​emermed-2012-202155CrossRefPubMed
Metadata
Title
Management of acute exacerbations of COPD in the emergency department and its associations with clinical variables
Authors
Ophir Freund
Ariel Melloul
Sabrina Fried
Eyal Kleinhendler
Avraham Unterman
Evgeni Gershman
Avishay Elis
Amir Bar-Shai
Publication date
11-04-2024
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 8/2024
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-024-03592-w

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar